Archives
-
Mycoplasma pneumoniae Resistance in Beijing Children
2026-08-21
A 2024 Frontiers study integrated antimicrobial susceptibility testing, resistance genotyping, strain typing, and clinical data from 62 pediatric Mycoplasma pneumoniae isolates collected in Beijing between 2021 and 2023. Its central finding was universal in vitro resistance to erythromycin and azithromycin, while acetylspiramycin showed lower MICs and therefore merits further evaluation as a 16-membered macrolide comparator in local antimicrobial resistance research.
-
Marein, ABCG2, and Mitoxantrone Resistance
2026-08-20
The reference study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug transporter. By increasing intracellular exposure to ABCG2 substrates, marein restored cancer-cell sensitivity to mitoxantrone, topotecan, and olaparib, suggesting a transporter-focused strategy for studying multidrug resistance.
-
IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis
2026-08-20
The 2025 reference study identifies an m6A-dependent IGF2BP1/THBS1/TLR4 pathway that links macrophage glycolytic reprogramming with profibrotic polarization in pulmonary fibrosis. Its knockdown, rescue, and metabolic analyses provide a mechanistic framework for studying how macrophage RNA regulation influences lung remodeling, while also defining important limits for translation into broader macrophage workflows.
-
Red Blood Cell Lysis Buffer for Bone Research
2026-08-19
Red Blood Cell Lysis Buffer can make mammalian blood sample preparation more consistent for flow cytometry, nucleic acid, and protein workflows. This article connects selective erythrocyte removal with the assay-design lessons of a RUNX2–AMPK osteoblast study while clarifying important translational limitations.
-
SEMA3E and β-Catenin in Beige Fat Thermogenesis
2026-08-19
This 2026 study identifies SEMA3E as a regulator of beige adipocyte differentiation and thermogenesis in mice. Through genetic perturbation, adipose transplantation, transcriptomics, mitochondrial respiration assays, and pathway rescue experiments, the authors connect SEMA3E activity with oxidative phosphorylation and regulated Wnt/β-catenin signaling.
-
ML216: A BLM Helicase Assay-to-Mechanism Guide
2026-08-18
ML216 is a BLM helicase inhibitor that connects DNA unwinding assays with mechanistic cancer biology. This guide distinguishes BLM-directed evidence from WRN-centered synthetic-lethality findings and provides a rigorous framework for biochemical, cellular, and translational experiments.
-
Adipose–Neural Axis in Cardiac Arrhythmias
2026-08-18
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY pathway. The study identifies Y1R, NCX, and CaMKII as mechanistic points associated with arrhythmogenesis and supports the relevance of this axis by analyzing epicardial adipose tissue and coronary sinus blood from patients with atrial fibrillation.
-
HBTU Peptide Synthesis: Reliable Workflows
2026-08-17
This scenario-based guide explains how HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), SKU A7023, can improve the reproducibility of peptide test articles used in cell viability and cytotoxicity studies. It separates documented reagent properties from peptide-level biological evidence and provides practical guidance on compatibility, storage, optimization, interpretation, and vendor selection.
-
Triacetin Digestion and Hepatic Metabolic Signaling
2026-08-17
This rat study clarifies how the short-chain triacylglycerol triacetin is digested, absorbed, and linked to hepatic metabolic regulation. Its central finding is that triacetin is degraded in the upper gastrointestinal tract into acetate and glycerol, which may act both as metabolic substrates and as signals influencing hepatic AMPK activity and lipid-related gene expression.
-
RSV NS3 Hijacks Host Signaling to Balance Pathogenicity
2026-08-16
Zhuang et al. show that Rice stripe virus NS3 uses phosphorylation and stage-dependent interactions with the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway to coordinate antiviral defense, pathogenicity, and transmission. The study provides a mechanistic model for virus–plant–vector co-survival and offers a useful framework for analyzing how pathogens tune host signaling rather than simply suppressing it.
-
ORM2, ZG16, and Autophagy in Pancreatic Fibrosis
2026-08-15
A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis, acting through ZG16 to limit autophagy-driven pancreatic stellate cell activation. Its combination of pancreas-specific gene manipulation, flux assays, and interaction studies provides a mechanistic framework for evaluating ORM2–ZG16 signaling in preclinical pancreatic fibrosis research.
-
PFHxS Hepatotoxicity Through PPARα in Zebrafish
2026-08-14
This study combines transcriptomics, liver pathology, biochemical measurements, targeted gene analysis, pharmacological antagonism, and PPARα morpholino knockdown to investigate PFHxS toxicity in larval zebrafish. Its findings link environmentally relevant PFHxS exposure with steatosis, necrosis, impaired liver function, and PPAR-associated molecular disruption, while also showing that pathway intervention can lessen several toxicological endpoints.
-
N-MYC/eIF4G1 Axis in inv(16) AML
2026-08-14
Peramangalam et al. identify a previously unrecognized MYCN enhancer and show that N-MYC supports inv(16) acute myeloid leukemia survival through the translation-initiation factor eIF4G1. By combining transcriptomic analysis, enhancer investigation, cellular perturbation, primary leukemia models, and xenografts, the study defines a mechanistic survival axis downstream of CBFβ-SMMHC-associated transcriptional disruption.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-08-13
The reference study identifies ALDOB lysine-87 lactylation as a metabolic control point linking hypoxia-driven glycolysis to DRP1-dependent mitochondrial fission in pulmonary hypertension. By combining lactylomic profiling, human pulmonary artery smooth muscle cell experiments, and rodent validation, the authors connect lactate accumulation with pathological vascular-cell behavior and define the SIRT1–ALDOB–DRP1 axis as a potential research target.
-
Bestatin and Endothelial Invasion in Fibrin Matrices
2026-08-13
The reference study showed that bestatin, an aminopeptidase inhibitor previously associated with anti-angiogenic activity, dose-dependently increased microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. Its results challenge the assumption that bestatin acts uniformly through CD13 inhibition and demonstrate why matrix composition, protease activity, and matrix integrity must be considered when interpreting angiogenesis assays.